Create a very simple easy flowchart cover the approach on heamoglobinopathy . Include everything simply

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Generating Image

A clean, simple medical flowchart titled "Approach to Haemoglobinopathy" with the following steps flowing downward with arrows: START BOX (green): "Patient with suspected Haemoglobinopathy" - Signs: pallor, jaundice, splenomegaly, family history, anaemia, frontal bossing, chronic haemolytic symptoms STEP 1 BOX (blue): "Step 1: Initial Investigations" - Full Blood Count (FBC/CBC): look for microcytic hypochromic anaemia, low MCV/MCH - Peripheral blood smear: target cells, sickle cells, fragmented cells - Reticulocyte count (elevated = haemolysis) DIAMOND DECISION (yellow): "Microcytic anaemia?" - YES arrow leads right → "Rule out Iron Deficiency First" (serum ferritin, iron studies) - NO arrow leads down After ruling out iron deficiency, merge back down STEP 2 BOX (blue): "Step 2: Specific Tests" - Haemoglobin electrophoresis / HPLC (key test!) → Identifies: HbS, HbC, HbE, HbA2 level, HbF level - Solubility test (for HbS/sickle cell) - Sickling test DIAMOND DECISION (yellow): "Abnormal Hb pattern?" - YES → leads to Classification Box - NO → Consider thalassaemia trait or normal STEP 3 BOX (orange): "Step 3: Classify the Disorder" Two branches: LEFT BRANCH - "Qualitative (structural variant)" • Sickle cell disease (HbSS) – HbS >90% • Sickle cell trait (HbAS) – HbS ~40% • HbC disease / HbE disease • HbS-beta thalassaemia compound RIGHT BRANCH - "Quantitative (thalassaemia)" • Beta-thalassaemia minor: ↑HbA2 (>3.5%) • Beta-thalassaemia major: HbA absent/reduced, ↑HbF • Alpha-thalassaemia: normal electrophoresis, HbH/Bart's on HPLC • Thalassaemia intermedia STEP 4 BOX (purple): "Step 4: Further Evaluation" - Molecular/DNA testing if diagnosis unclear or complex - Family studies / partner testing - Serum bilirubin, LDH, haptoglobin (haemolysis markers) - End-organ assessment (liver, spleen, heart) FINAL BOX (green): "Step 5: Management" - Trait/carrier: genetic counselling - Sickle cell disease: hydroxyurea, folic acid, vaccination, pain management, exchange transfusion - Thalassaemia major: regular transfusions + iron chelation, BMT - Prenatal screening if couple at risk Style: clean white background, clear bold text, pastel colored boxes, simple straight arrows, professional medical education style. Easy to read at a glance.

Approach to Haemoglobinopathy Flowchart
Here is the complete simple flowchart covering the approach to haemoglobinopathy. Here is a quick summary of what it covers:

The 5-Step Approach:
  1. Clinical Suspicion - Pallor, jaundice, splenomegaly, chronic anaemia, family history, frontal bossing
  2. Initial Investigations - FBC (look for low MCV/MCH), peripheral blood smear (target cells, sickle cells), reticulocyte count
  3. Key Diagnostic Test: Hb Electrophoresis / HPLC - This is the cornerstone test. It identifies HbS, HbC, HbE, HbA2 and HbF levels. Always rule out iron deficiency first if microcytic anaemia is present.
  4. Classify the Disorder:
    • Qualitative (structural): Sickle cell disease, HbC, HbE, compound heterozygotes
    • Quantitative (thalassaemia): Beta-thal minor (raised HbA2 >3.5%), Beta-thal major (absent HbA, raised HbF), Alpha-thal (normal electrophoresis, HbH on HPLC)
  5. Management:
    • Carriers: genetic counselling + partner screening
    • Sickle cell disease: hydroxyurea, folic acid, vaccinations
    • Thalassaemia major: transfusions + iron chelation, consider BMT

Key rule to remember: Always exclude iron deficiency before interpreting Hb electrophoresis - iron deficiency suppresses HbA2 and can mask thalassaemia trait.

Make the flowchart decision making on finding the type of heamoglobinopathy in peadiatrics

Finding Sources
Finding Sources
Reading File
Finding Sources
Loading Image
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Generating Image

A detailed, clean, professional medical decision-making flowchart titled "Paediatric Haemoglobinopathy: Finding the Type" on a white background. The flowchart uses a top-down structure with clearly labeled decision diamonds (yellow), process boxes (light blue), and outcome/diagnosis boxes (green for benign/carrier, red/orange for significant disease). Use bold black text, clear arrows with labels YES/NO or specific values. Layout and content: TOP ENTRY BOX (grey): "Child with suspected haemoglobinopathy" → subtext: "Pallor, jaundice, splenomegaly, haemolytic anaemia, family history, at-risk ethnicity (African, South Asian, Mediterranean, Middle Eastern), or newborn screening result" ↓ Arrow BLUE BOX: "STEP 1: Full Blood Count (FBC) + Blood Film" • Check: Hb level, MCV, MCH, RBC count • Blood film: target cells, sickle cells, nucleated RBCs, hypochromia, anisocytosis ↓ Arrow YELLOW DIAMOND: "Is MCV/MCH low? (MCV <70 fL, MCH <27 pg)" YES arrow → RIGHT BLUE BOX: "Exclude Iron Deficiency First" • Serum ferritin, iron studies • Treat if deficient, recheck FBC in 6–8 weeks → YELLOW DIAMOND: "Still low MCV after iron?" YES → Proceed to HPLC NO → GREEN BOX: "Iron Deficiency Anaemia — Treat" NO arrow (normal MCV) → Straight down Both paths converge ↓ BLUE BOX: "STEP 2: HPLC (High Performance Liquid Chromatography) + Haemoglobin Electrophoresis" • Gold standard test • Note: In neonates — HbF predominates, HbA appears by age 3–6 months • Report all Hb fractions: HbA, HbA2, HbF, HbS, HbC, HbE, HbH, HbBart's ↓ Arrow YELLOW DIAMOND: "What does the HPLC show?" Four branches fanning out below: BRANCH 1 (left-most): "HbS present" → YELLOW DIAMOND: "HbA also present?" YES (HbA present ~55%, HbS ~40%) → GREEN BOX: "Sickle Cell TRAIT (HbAS) — Carrier. Usually asymptomatic. Genetic counselling." NO (HbS >85–90%, no HbA) → YELLOW DIAMOND: "Any other Hb?" HbS only + HbF → RED BOX: "Sickle Cell Disease (HbSS) — Sickle Cell Anaemia" HbS + HbC → ORANGE BOX: "HbSC Disease — Moderate severity" HbS + HbF + small HbA → ORANGE BOX: "HbS-Beta+ Thalassaemia — Variable severity" HbS + HbF only (no HbA) → RED BOX: "HbS-Beta0 Thalassaemia — Severe, similar to SCD" BRANCH 2: "HbA2 elevated (>3.5%)" → YELLOW DIAMOND: "HbA present?" YES, Hb normal/mildly low → GREEN BOX: "Beta-Thalassaemia TRAIT (Minor) — Carrier. Asymptomatic/mild anaemia." NO HbA, high HbF (>90%) → RED BOX: "Beta-Thalassaemia MAJOR (Cooley's anaemia) — Severe, transfusion-dependent" Some HbA, raised HbF, moderate anaemia → ORANGE BOX: "Beta-Thalassaemia INTERMEDIA — Moderate, may not need transfusions" BRANCH 3: "Normal HPLC but low MCV/MCH, normal HbA2" → BLUE BOX: "Suspect ALPHA-Thalassaemia" → DNA/molecular testing or MCV <70 in family → YELLOW DIAMOND: "How many alpha genes deleted?" 1 gene → GREEN BOX: "Silent Carrier — Normal" 2 genes → GREEN BOX: "Alpha-Thal Trait — Mild microcytosis, asymptomatic" 3 genes (HbH on HPLC) → ORANGE BOX: "HbH Disease — Moderate haemolytic anaemia" 4 genes → RED BOX: "Hb Barts (Hydrops Fetalis) — Fatal without intervention" BRANCH 4 (right-most): "HbE or HbC present" → YELLOW DIAMOND: "Homozygous or compound?" HbEE or HbCC → ORANGE BOX: "Mild haemolytic anaemia — moderate disease" HbE/Beta-Thal → RED BOX: "HbE-Beta Thalassaemia — Severe (common in SE Asia)" Heterozygous HbE or HbC → GREEN BOX: "HbE or HbC Trait — Carrier, mild or no symptoms" BOTTOM SECTION — all paths lead down to: PURPLE BOX: "STEP 3: Confirmatory Tests if needed" • Molecular/DNA testing for alpha-thal or complex cases • Parental testing (to confirm inheritance pattern) • Osmotic fragility test • Reticulocyte count, bilirubin, LDH (haemolysis markers) • Bone marrow (only if diagnosis unclear) ↓ Arrow FINAL GREEN BOX: "STEP 4: Classify & Act" • Carrier/Trait → Genetic counselling, partner screening, reassurance • Mild disease (HbSC, HbH, Intermedia) → Monitor, folic acid, avoid triggers • Severe disease (HbSS, Beta-Thal Major, HbE/Beta-Thal) → Haematology referral, transfusion programme, hydroxyurea, iron chelation, consider HSCT Style: Clean white background, professional medical education style, pastel-colored boxes (light blue for process, yellow for decisions, green for benign outcomes, orange for moderate, red for severe), bold black labels, neat connecting arrows with clear YES/NO labels. Adequate spacing so all text is clearly readable.

This is a shared conversation. Sign in to Orris to start your own chat.